Newsletter | July 30, 2020

07.30.20 -- Tips For Navigating Clinical Trials During COVID-19

 
COVID-19 Changed Everything: Now Contracts And Budgets Need To Catch Up
 

As we emerge from crisis-response mode we find ourselves in a period of transition and uncertainty. While much remains unresolved, we do know this: Sites and sponsors will be recalibrating everything, especially budgets for either new components of trials or changes to clinical trials. This article outlines five critical changes sites and sponsors should be considering to best plan for the future.

Four Tips For Navigating Patient Recruitment During COVID-19
 

The COVID-19 pandemic has caused unprecedented disruptions to our lives and to clinical research, with many clinical trials pausing new enrollment on studies. By being proactive and engaging with your existing patients during this time, your site can prepare for when clinical trials begin screening patients again. Here are four actions your site can take to ensure recruitment readiness during the pandemic.

COVID-19 Doesn’t Play Fair: What We Need to Understand About Racial Disparities
 

This episode takes on a topic from recent headlines: namely, the racial disparity in COVID-19 cases and deaths. Edith P. Mitchell, MD, MACP, FCPP, shares her insights on the causes of these health disparities and how they relate to the coronavirus. Contributing factors include less access to testing, lack of insurance and paid time off, underlying health conditions, and the spread of misinformation about the virus.

There Is Value To Patients When Independent Sites Offer Clinical Trials
 

The COVID-19 pandemic suddenly changed the clinical trials environment with impacts on all stakeholders that at first are negative, but could be positive in the long term. There is talk of transformation that could last well beyond the crisis. In this transformative time, independent sites may be faster to pivot to new ways of operating.